The downregulation of paxillin resulted in a reduced invasion of primary breast tumors and made tumor organoids less invasive in 3D collagen cultures [64], whereas the overexpression of paxillin made cancer cells more aggressive [33,73]. This evidence concerns the gene PXN and neoplasm.